SOX14_XENLA
ID SOX14_XENLA Reviewed; 239 AA.
AC B0ZTE2;
DT 16-JUN-2009, integrated into UniProtKB/Swiss-Prot.
DT 08-APR-2008, sequence version 1.
DT 03-AUG-2022, entry version 60.
DE RecName: Full=Transcription factor Sox-14 {ECO:0000250|UniProtKB:Q9W7R6};
DE AltName: Full=SRY (sex determining region Y)-box 14;
GN Name=sox14 {ECO:0000312|EMBL:ABY90181.1};
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1] {ECO:0000305, ECO:0000312|EMBL:ABY90181.1}
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PUTATIVE FUNCTION, TISSUE SPECIFICITY,
RP AND DEVELOPMENTAL STAGE.
RX PubMed=18956331; DOI=10.1387/ijdb.082586dc;
RA Cunningham D.D., Meng Z., Fritzsch B., Casey E.S.;
RT "Cloning and developmental expression of the soxB2 genes, sox14 and sox21,
RT during Xenopus laevis embryogenesis.";
RL Int. J. Dev. Biol. 52:999-1004(2008).
CC -!- FUNCTION: Acts as a negative regulator of transcription (By
CC similarity). May function as a switch in neuronal development.
CC {ECO:0000250|UniProtKB:Q9W7R6, ECO:0000269|PubMed:18956331}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9W7R6,
CC ECO:0000255|PROSITE-ProRule:PRU00267}.
CC -!- TISSUE SPECIFICITY: In the developing embryo, restricted to the
CC hypothalamus, dorsal thalamus, optic tectum, a region of the somatic
CC motornucleus in the midbrain and hindbrain, the vestibular nuclei in
CC the hindbrain, and a discrete ventral domain in the developing spinal
CC cord. {ECO:0000269|PubMed:18956331}.
CC -!- DEVELOPMENTAL STAGE: First expressed at stage 25. Expression peaks at
CC stage 28 and continues at this level throughout all later stages, until
CC at least stage 38. {ECO:0000269|PubMed:18956331}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; EU403425; ABY90181.1; -; Genomic_DNA.
DR RefSeq; NP_001165685.1; NM_001172214.1.
DR AlphaFoldDB; B0ZTE2; -.
DR SMR; B0ZTE2; -.
DR MaxQB; B0ZTE2; -.
DR GeneID; 100337614; -.
DR KEGG; xla:100337614; -.
DR CTD; 100337614; -.
DR Xenbase; XB-GENE-6458188; sox14.S.
DR OMA; SAHAPAM; -.
DR OrthoDB; 1335452at2759; -.
DR Proteomes; UP000186698; Chromosome 5S.
DR Bgee; 100337614; Expressed in brain and 1 other tissue.
DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR GO; GO:0007399; P:nervous system development; IEP:UniProtKB.
DR Gene3D; 1.10.30.10; -; 1.
DR InterPro; IPR009071; HMG_box_dom.
DR InterPro; IPR036910; HMG_box_dom_sf.
DR InterPro; IPR029549; SOX-14.
DR InterPro; IPR022097; SOX_fam.
DR PANTHER; PTHR10270:SF107; PTHR10270:SF107; 1.
DR Pfam; PF00505; HMG_box; 1.
DR Pfam; PF12336; SOXp; 1.
DR SMART; SM00398; HMG; 1.
DR SUPFAM; SSF47095; SSF47095; 1.
DR PROSITE; PS50118; HMG_BOX_2; 1.
PE 2: Evidence at transcript level;
KW Developmental protein; DNA-binding; Nucleus; Reference proteome; Repressor;
KW Transcription; Transcription regulation.
FT CHAIN 1..239
FT /note="Transcription factor Sox-14"
FT /id="PRO_0000378069"
FT DNA_BIND 8..76
FT /note="HMG box"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
SQ SEQUENCE 239 AA; 26865 MW; DE32D616AD01C977 CRC64;
MSKPVDHIKR PMNAFMVWSR GQRRKMAQEN PKMHNSEISK RLGAEWKLLS EAEKRPYIDE
AKRLRAQHMK EHPDYKYRPR RKPKNLLKKD RYVFPLPYFG DHDPLKTGLS MSATDSILGA
SEKARAFFPP TSTPYSLLDP SHFSSTTIQK MTEMPHTLAT STLPYASTLG YQNGAFGGLS
CPSQHTHTHP SPTNPGYVVP CNCTAWSASN LQPPVAYILF PGMTKAGIDP YSSAHTTAM